Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol
Main Authors: | A Eden Evins, Ellie Grossman, Julia Jashinski, Aurora Quaye, Corinne Cather, Kevin Potter, David A Schoenfeld, Jodi M Gilman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e064457.full |
Similar Items
-
Food insecurity, chronic pain, and use of prescription opioids
by: Fei Men, et al.
Published: (2021-06-01) -
Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study.
by: Jacob M Vigil, et al.
Published: (2017-01-01) -
Genetics and Opioids: Towards More Appropriate Prescription in Cancer Pain
by: Dario Bugada, et al.
Published: (2020-07-01) -
Pain management, prescription opioid mortality, and the CDC: is the devil in the data?
by: Schatman ME, et al.
Published: (2017-10-01) -
Overdose, opioid treatment admissions and prescription opioid pain reliever relationships: United States, 2010–2019
by: Larry Aubry, et al.
Published: (2022-08-01)